P Jeffery Conn

Title: P Jeffery Conn: Innovator in Neurological Treatments

Introduction

P Jeffery Conn is a prominent inventor based in Nashville, TN (US). He is known for his significant contributions to the field of pharmacology, particularly in the development of treatments for neurological and psychiatric disorders. His innovative work has led to the creation of valuable pharmaceutical compounds that have the potential to improve patient outcomes.

Latest Patents

Conn holds a patent for "Positive allosteric modulators of the muscarinic acetylcholine receptor M1." This patent describes positive allosteric modulators of muscarinic acetylcholine receptor M1 (mAChR M1). The patent outlines pharmaceutical compositions that include these compounds and methods for using them to treat neurological disorders, psychiatric disorders, or a combination thereof. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Conn is affiliated with Vanderbilt University, where he conducts research and collaborates with other experts in the field. His work at the university has positioned him as a leader in the study of muscarinic receptors and their role in various disorders. His research has garnered attention for its potential to lead to new therapeutic strategies.

Collaborations

Throughout his career, Conn has worked alongside notable colleagues, including Craig William Lindsley and Darren W Engers. These collaborations have enriched his research and contributed to the development of innovative solutions in pharmacology.

Conclusion

P Jeffery Conn's contributions to the field of pharmacology, particularly through his patent on positive allosteric modulators, highlight his role as an influential inventor. His work at Vanderbilt University and collaborations with esteemed colleagues further emphasize his commitment to advancing treatments for neurological and psychiatric disorders.